Qnovia

Digital

Health Innovators – Brian Quigley and Mario Danek (Live from...

At HLTH last month, pharmaphorum Editor in Chief Jonah Comstock sat down with the CEO and CTO respectively of QNovia, Brian Quigley and Mario Danek.

News

JPM: AbbVie pays $650m upfront for RemeGen cancer drug

AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks